John Blazeck

2.9k total citations · 1 hit paper
27 papers, 2.0k citations indexed

About

John Blazeck is a scholar working on Molecular Biology, Biomedical Engineering and Genetics. According to data from OpenAlex, John Blazeck has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Biomedical Engineering and 6 papers in Genetics. Recurrent topics in John Blazeck's work include Microbial Metabolic Engineering and Bioproduction (11 papers), CRISPR and Genetic Engineering (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). John Blazeck is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (11 papers), CRISPR and Genetic Engineering (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). John Blazeck collaborates with scholars based in United States. John Blazeck's co-authors include Hal S. Alper, Leqian Liu, A.D. Hill, Peter B. Otoupal, David H. Munn, Dacia Leon, Kelly A. Markham, Verónica Costantini, George Georgiou and Jonathan R. McDaniel and has published in prestigious journals such as Nature Communications, Immunity and PLoS ONE.

In The Last Decade

John Blazeck

25 papers receiving 2.0k citations

Hit Papers

Harnessing Yarrowia lipolytica lipogenesis to create a pl... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Blazeck United States 14 1.8k 808 214 107 77 27 2.0k
Goutham N. Vemuri Sweden 17 1.7k 0.9× 676 0.8× 269 1.3× 69 0.6× 116 1.5× 20 1.9k
Sorena Rahmanian United States 5 1.4k 0.7× 559 0.7× 104 0.5× 28 0.3× 33 0.4× 7 1.5k
Jochem Gätgens Germany 15 1.0k 0.6× 365 0.5× 118 0.6× 113 1.1× 52 0.7× 31 1.2k
Franz Stefan Hartner Austria 12 1.1k 0.6× 305 0.4× 99 0.5× 161 1.5× 56 0.7× 14 1.3k
Sung Sun Yim South Korea 20 1.1k 0.6× 334 0.4× 177 0.8× 91 0.9× 41 0.5× 35 1.3k
Petri‐Jaan Lahtvee Estonia 18 1.2k 0.7× 545 0.7× 122 0.6× 45 0.4× 34 0.4× 30 1.4k
Andrea Camattari Austria 13 757 0.4× 311 0.4× 58 0.3× 156 1.5× 36 0.5× 19 1.0k
Laura Frontali Italy 26 1.7k 0.9× 229 0.3× 107 0.5× 80 0.7× 62 0.8× 82 1.9k
Sungho Jang South Korea 18 1.0k 0.6× 299 0.4× 152 0.7× 57 0.5× 18 0.2× 41 1.2k

Countries citing papers authored by John Blazeck

Since Specialization
Citations

This map shows the geographic impact of John Blazeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Blazeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Blazeck more than expected).

Fields of papers citing papers by John Blazeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Blazeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Blazeck. The network helps show where John Blazeck may publish in the future.

Co-authorship network of co-authors of John Blazeck

This figure shows the co-authorship network connecting the top 25 collaborators of John Blazeck. A scholar is included among the top collaborators of John Blazeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Blazeck. John Blazeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yellman, Christopher M., Hee Jun Lee, Hathaichanok Phuengkham, et al.. (2025). A facile yeast-display approach for antibody mask discovery. Protein Engineering Design and Selection. 38. 1 indexed citations
2.
Allen, Christopher, et al.. (2025). Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation. Genome biology. 26(1). 164–164. 5 indexed citations
3.
Blazeck, John, et al.. (2024). Engineering CREB‐activated promoters for adenosine‐induced gene expression. Biotechnology Journal. 19(2). e2300446–e2300446. 2 indexed citations
4.
Blazeck, John, et al.. (2024). Exploiting protein domain modularity to enable synthetic control of engineered cells. Current Opinion in Biomedical Engineering. 31. 100550–100550. 1 indexed citations
5.
Blazeck, John, et al.. (2023). Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies. Immuno-Oncology Technology. 19. 100394–100394. 3 indexed citations
6.
Blazeck, John, et al.. (2023). Optimized expression and purification of a human adenosine deaminase in E. coli and characterization of its Asp8Asn variant. Protein Expression and Purification. 213. 106362–106362. 1 indexed citations
7.
Blazeck, John, et al.. (2022). High throughput mutagenesis and screening for yeast engineering. Journal of Biological Engineering. 16(1). 37–37. 7 indexed citations
8.
Blazeck, John, et al.. (2021). Advances in promoter engineering: Novel applications and predefined transcriptional control. Biotechnology Journal. 16(10). e2100239–e2100239. 75 indexed citations
9.
Blazeck, John, et al.. (2021). Protein engineering: a driving force toward synthetic immunology. Trends in biotechnology. 40(4). 509–521. 3 indexed citations
10.
Lindesmith, Lisa C., Jonathan R. McDaniel, Anita Changela, et al.. (2019). Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination. Immunity. 50(6). 1530–1541.e8. 78 indexed citations
11.
Blazeck, John, et al.. (2015). Metabolic engineering of Yarrowia lipolytica for itaconic acid production. Metabolic Engineering. 32. 66–73. 107 indexed citations
12.
Liu, Leqian, Kelly A. Markham, John Blazeck, et al.. (2015). Surveying the lipogenesis landscape in Yarrowia lipolytica through understanding the function of a Mga2p regulatory protein mutant. Metabolic Engineering. 31. 102–111. 62 indexed citations
13.
Blazeck, John, et al.. (2014). Harnessing Yarrowia lipolytica lipogenesis to create a platform for lipid and biofuel production. Nature Communications. 5(1). 3131–3131. 489 indexed citations breakdown →
14.
Blazeck, John, et al.. (2014). Metabolic engineering of Saccharomyces cerevisiae for itaconic acid production. Applied Microbiology and Biotechnology. 98(19). 8155–8164. 80 indexed citations
15.
Lanza, Amanda M., John Blazeck, Nathan Crook, & Hal S. Alper. (2012). Linking Yeast Gcn5p Catalytic Function and Gene Regulation Using a Quantitative, Graded Dominant Mutant Approach. PLoS ONE. 7(4). e36193–e36193. 10 indexed citations
16.
Blazeck, John, et al.. (2012). Evolution of an alkane-inducible biosensor for increased responsiveness to short-chain alkanes. Journal of Biotechnology. 158(3). 75–79. 41 indexed citations
17.
Blazeck, John & Hal S. Alper. (2012). Promoter engineering: Recent advances in controlling transcription at the most fundamental level. Biotechnology Journal. 8(1). 46–58. 245 indexed citations
18.
Blazeck, John, et al.. (2012). Controlling promoter strength and regulation in Saccharomyces cerevisiae using synthetic hybrid promoters. Biotechnology and Bioengineering. 109(11). 2884–2895. 233 indexed citations
19.
Blazeck, John, et al.. (2012). Generalizing a hybrid synthetic promoter approach in Yarrowia lipolytica. Applied Microbiology and Biotechnology. 97(7). 3037–3052. 106 indexed citations
20.
Blazeck, John & Hal S. Alper. (2010). Systems metabolic engineering: Genome‐scale models and beyond. Biotechnology Journal. 5(7). 647–659. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026